Brief: Agile Therapeutics Reports Q4 Loss Per Share Of $0.20

Agile Therapeutics

01/03/2021 21:39

March 1 (Reuters) - Agile Therapeutics Inc  AGRX.O :
    * AGILE THERAPEUTICS REPORTS FOURTH QUARTER & FULL YEAR 2020
FINANCIAL RESULTS; EXPANDS LOAN FACILITY WITH PERCEPTIVE
ADVISORS
    * Q4 LOSS PER SHARE $0.20
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.22 -- REFINITIV IBES
DATA
    * PERCEPTIVE ADVISORS INCREASES CREDIT FACILITY TO $45
MILLION,
WITH $25 MILLION POTENTIALLY AVAILABLE
    * ON FEB 24, 2021, ENTERED INTO AGREEMENT WITH STERLING
SPECIALTY
PHARMACY
    * ACHIEVED JUST OVER $1 MILLION IN GROSS REVENUE IN Q4

Source text for Eikon:  ID:nGNX9Pm3q5 
Further company coverage:  AGRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))